ipamorelin and tesamorelin vs. Tesamorelin: Understanding the Differences 16137828 Tesamorelin + Ipamorelin | Targeted

A.PavlivO.SeidelL.LiJ.et al

Journal of TCI is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence, unless otherwise stated

At the origin of these divergences, several possible factors may be hypothesized, such as non-homogeneous populations selection, temporal discrepancies between competitive risk factors and influence of common complication including inflammation and protein-energy wasting (PEW) that could influence circulating homocysteine and that are associated with poorer outcomes [9]

This is due to the elevated cellular vulnerability to oxidative stress and reactive oxygen species (Gawryluk et al., 2011)

Payet M, Dargai F, Gasque P, Guillot X